Cite
HARVARD Citation
Patel, D. et al. (n.d.). 2241 Outcome of peptide receptor radionuclide therapy with 177Luoctreotate in advanced neuroendocrine tumours (NET): South Australian sub study of the SIGNETURe Registry. European journal of cancer. pp. S413-. [Online].